# Cannabis Brands on Google Ads: The Canadian Pilot Program and What It Means for the US

> You’ve spent weeks perfecting your creative. The copy is punchy, the visuals are on-brand, and your landing page is optimized for conversions. You hit "Publish" on your latest campaign, feeling a surge of excitement. Then, the dreaded email hits your inbox: "Account Suspended: Policy Violation."

HawtAds team · April 2, 2026 · 8 min read

Source: <https://hawtads.com/blog/cannabis-brands-on-google-ads-the-canadian-pilot-program-and-what-it-means-for-the-us>

![Cannabis Brands on Google Ads: The Canadian Pilot Program and What It Means for the US](https://hawtads.com/blog/media/ghost/content/images/2026/04/1775964580078-v1techam41g.jpg)

Google opened cannabis advertising in Canada in August 2025, on Search only, and only to advertisers holding a federal Health Canada licence. That pilot is the closest thing to a preview of how a US program would work, which is why US brands watch it more closely than any policy blog.

The Canadian rules arrived through a change-log update to Google's cannabis policy. The pilot came with strict conditions. In Google's words: "This pilot will run on Search only, beginning Aug 25, 2025", and "Participation in this pilot is restricted to entities holding federal Health Canada licenses for Cultivation, Processing, or Sale for Medical Purposes, as well as provincially and territorially authorized government operators and private retailers." Licensed producers and retailers could finally bid on keywords that had been closed to them for years.

For US brands, the useful question is what the pilot reveals about Google's conditions, its costs, and the order in which a US program would open. Google processes over 8.5 billion searches per day, and cannabis brands have been excluded from that intent-based traffic for years.

## The Canadian pilot is a licensing test, not an open door

Canada works as a laboratory because cannabis is legal across the entire country. Google does not have to reconcile fifty state laws with a federal prohibition. It can write one policy, verify one license, and see whether the enforcement holds.

The pilot also answers a question US operators ask constantly: whether a search channel can move product at the store level. The Canadian data says it can, at least for retailers with a licensed location and a clean account.

The commercial case is straightforward. Canada's legal retail network is dense enough that most customers already have a licensed store within reach. Allowing dispensary Google Ads lets those stores reach people who are already searching for a product nearby, instead of forcing them into organic SEO or expensive billboards.

One detail matters more than the rest: Google did not write a cannabis policy. It wrote a licensing policy, and cannabis happens to be the category. Any US program will follow the same shape, which means the work of proving who you are starts long before the first ad.

The lesson for the US is that federal legalization is the switch, not the strategy. A US program would still need per-state licensing checks, and those checks would be harder than Canada's because the underlying law is fragmented.

### The LegitScript hurdle

You cannot log into a dashboard and start bidding on "best sativa." The Canadian pilot introduced a mandatory gatekeeper: LegitScript. To run ads, a brand must complete a certification process that proves it is licensed and compliant with local regulations.

That certification is more than a rubber stamp. It examines business practices, supply chain, and digital presence. Google is outsourcing part of its compliance work to a third party that specializes in high-risk industries, and the standard is set by that third party.

The documentation burden is the part that surprises operators. Licenses, ownership records, and the link between the licensed entity and the ad account all have to line up, and a mismatch sends the application back to the start of the queue.

LegitScript charges a significant fee, which acts as a barrier to entry. The fee keeps the platform cleaner and makes Google Ads cannabis a pay-to-play channel where the most professional and compliant brands survive. We expect the same structure in the US as soon as federal restrictions ease.

## What the US allows today

US policy is far more restrictive. Google primarily allows hemp-derived CBD products with a THC content of 0.3% or less. THC cannabis remains outside the policy for most advertisers.

The size of the prize explains the interest. Google is a business, and it does not want to leave that revenue on the table indefinitely. The Canadian program is how it builds the verification and enforcement systems it would need before a US market opens.

The practical gap is smaller than the policy gap suggests. A US brand that can pass a state licensing check, keep a landing page clean, and produce creative that avoids medical claims is already doing most of what a US program would require. The missing piece is a certification process that does not exist yet.

Most brands are waiting for the law to change before they build a strategy. The ones that will be ready have already learned how Google's moderation reads creative, so they can move on the day the policy shifts.

### The rescheduling question

The federal classification of marijuana is the main structural obstacle. The Department of Health and Human Services has recommended moving cannabis from Schedule I to Schedule III, which would acknowledge medical utility and could open the door to broader advertising permissions.

If rescheduling happens, a Canadian-style policy could be ported to the US faster than most teams expect. Google's recreational drugs policy already draws a narrow US line: "Ads for topical, hemp-derived cannabidiol (CBD) products with THC content of 0.3% or less are allowed", and FDA-approved pharmaceutical CBD advertisers may target only California, Colorado and Puerto Rico. Nothing in the policy covers THC cannabis at retail.

The transition from prohibited to regulated tends to happen in one policy update. A brand with no approved creative, no certified account, and no compliance record will spend the first months of that window catching up.

## Why Google is strict

Google's primary concern is liability, not the morality of cannabis. It operates in hundreds of jurisdictions with different rules. An ad that violates a local law exposes the company to fines and legal action.

The review is not a single gate. Account health, landing page behavior, and the history of prior disapprovals all feed the same decision, which is why one weak page can cost a campaign that never mentioned the product.

That is why its review systems run at high sensitivity for regulated categories. An ad can be technically legal and still trip an algorithm on a single word or image, and the penalty can reach the whole account. The system behaves as if guilt is the default until proof arrives.

Images of people consuming the product, excessive amounts of flower, and unsubstantiated health claims are all red flags. A landing page with a Buy Now button for a restricted product can get an entire Google Ads account suspended, even when the ad itself is clean.

### The cost of manual review

Many brands manage compliance by hand, with one team member reviewing every ad against a checklist. People make mistakes, and Google's policies change often. Manual ad compliance checks take hours a marketing team would rather spend on strategy and creative.

The cost of a disapproval is larger than the lost review hours. Google keeps a compliance history, and repeated disapprovals make every future approval harder. You are teaching the system that your brand is high risk.

The revenue loss is concrete. For a mid-sized dispensary, 48 hours of downtime during a peak period like 4/20 can mean tens of thousands of dollars in lost sales. That is why platforms like [Hawtads](https://hawtads.com/) become part of the conversation for brands that want to scale without living under suspension risk.

## Creative that survives review

Success in dispensary Google Ads depends on saying something true in a way the review system can accept. In Canada, the brands that pass review have moved away from stoner aesthetics toward wellness and lifestyle. They sell the benefit rather than the burn. Instead of a close-up of a terpene-rich bud, they show a person enjoying a quiet evening or a social setting where the product fits.

That shift costs something. Wellness creative is less distinctive than the category's older visual language, and a brand that sounds like every other dispensary is safe and forgettable. The tradeoff is real, and the answer is usually to keep the differentiation in the offer and the photography rather than in the claims.

Four practices do most of the work:

- **Focus on education.** Instead of "Buy 1/8th of OG Kush," try "Learn about the differences between Indica and Sativa."
- **Use neutral language.** Avoid slang and use clinical or professional terms where they fit.
- **Optimize the landing page.** Google reviews where the ad leads, not only the ad. The destination has to be as compliant as the creative.
- **Use video where it fits.** Short, compliant video ads often engage better and can avoid some of the text-based filters that catch static ads.

The goal of a Google Ads cannabis campaign is not always a direct sale. Sometimes it is awareness and an email address, so the brand can market on channels it owns. Search ads that build an owned audience are worth more than a single conversion, because the audience survives a policy change.

### The power of informational search

One of the most effective uses of Google Ads today, even in the US, is bidding on informational keywords. People search for how to dose CBD for sleep, or what a terpene is. Answering those questions well builds trust and authority.

Educational content earns the click that a product page cannot, because it answers the question the person actually typed. Positioning the brand as an educator rather than a seller also makes the account harder to classify as high risk.

### Data-driven compliance

Compliance tracking follows a similar logic. By tracking which creative earns a better Quality Score, a team can find the version that gets approved and delivered. A higher Quality Score means lower cost per click and better placement, and a 10% reduction in CPC can separate a profitable campaign from a money pit.

## The future of cannabis PPC

As the Canadian pilot matures and the US moves closer to federal reform, the volume of cannabis ads will rise. Manual management will not keep up at that volume, and the brands that dominate search results will be the ones using AI to run creative and compliance at the same time.

Google is investing heavily in automation, and Performance Max is the clearest example. A brand competing for the same inventory needs tooling that understands the category's rules, including the difference between a promotion and a product description in the eyes of a reviewer.

## What to do before the rules change

The Canadian pilot is a preview of the rules, the hurdles, and the opportunities that will reach the US. Four steps are worth taking now.

1. **Audit your current assets.** Review the website and social channels for language that would fail a LegitScript-style review.
2. **Monitor the Canadian market.** Watch what large Canadian players such as Canopy Growth and Tilray do with search ads. They are paying for lessons you can watch for free.
3. **Build an educational content base.** Create compliant, informational content for high-intent search terms. It builds SEO and prepares the account for future paid search.
4. **Invest in compliance technology.** Do not wait for a suspension to learn that manual review does not scale. Look for tools that check creative before it reaches the platform.

None of that requires a policy change to start. The assets, the education library, and the review process are all work a team can do while the rules are still closed, and they are the parts that take longest once the door opens.

What was impossible yesterday is a pilot program today and may be an industry standard tomorrow. The question is whether your brand will have approved creative, a certified account, and a compliance record when that happens.

The pilot has already done the expensive part. It proved that a search platform can verify a cannabis advertiser and police the creative without losing control of the category, which is the argument a US policy team would need.

[Hawtads](https://hawtads.com/) is a general ad creation tool with additional features for regulated verticals, including creative checks against platform policy. It handles the production and review work, so a team can spend its attention on the market instead of on the paperwork that surrounds a policy change.
